✦ LIBER ✦

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)

✍ Scribed by F Maindrault-Goebel; C Louvet; T André; E Carola; J.P Lotz; J.L Molitor; M.L Garcia; V Gilles-Amar; V Izrael; M Krulik; A de Gramont

Book ID: 117666807
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 141 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(99)00149-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose intensity oxaliplatin added to

High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)

✍ F Maindrault-Gœbel; A de Gramont; C Louvet; T André; E Carola; M Mabro; P Artru; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Erratum to “High-dose intensity oxalipla

Erratum to “High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as a second-line therapy for metastatic colorectal cancer (FOLFOX 7)” [European Journal of Cancer 37 (2001) 1000–1005]

✍ F. Maindrault-Gœbel; A. de Gramont; C. Louvet; T. André; E. Carola; M. Mabro; P. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Capecitabine plus oxaliplatin (XELOX) ve

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer

✍ Michel Ducreux; Jaafar Bennouna; Mohamed Hebbar; Marc Ychou; Gérard Lledo; Thier 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 440 KB

## Abstract A regimen consisting of 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) is widely used in France in the first‐line treatment of metastatic colorectal cancer (MCRC). The aim of our study was to demonstrate the non‐inferiority of capecitabine plus oxaliplatin (XELOX) __versus__ FOLF

Irinotecan plus folinic acid/continuous

Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer

✍ Andreas Teufel; Silke Steinmann; Jürgen Siebler; Christiane Zanke; Herbert Hohl; 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 301 KB

Bevacizumab plus irinotecan, 5-fluoroura

Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as the second-line therapy for patients with metastatic colorectal cancer, a multicenter study

✍ Deng, Ting; Zhang, Le; Liu, Xiao-jian; Xu, Jian-ming; Bai, Yu-xian; Wang, Yan; H 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 199 KB

A randomized phase II study to compare o

A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer

✍ Cristina Gravalos, Antonieta Salut, Carlos García-Girón, Rocío García-Carbonero, 📂 Article 📅 2012 🏛 Springer Milan 🌐 Spanish ⚖ 294 KB